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Abstract 
Introduction: Hepatocellular carcinoma (HCC) is sixth common cancers worldwide and 
predominant in Asia and Africa. A number of evidence suggests a possible role of midkine 
(MDK) and α-fetoprotein (AFP) in the pathogenesis of hepatocellular carcinoma (HCC). 
Materials and methods: We studied MDK and AFP in patients with HCC or in healthy 
controls. MDK and AFP was measured by enzyme linked immunosorbent assay and 
chemiluminescent immunoassay, respectively in 30 patients with primary hepatocellular 
carcinoma and 30 normal subjects. 
Results: MDK and AFP were found in high levels in the serum of patients initially diagnosed 
with HCC (18 ± 9.8 pg/ml and 492.01 ± 298.89 pg/ml) compared with healthy subjects     
(4.29 ± 2.10 pg/ml and 3.13 ± 1.27 pg/ml), respectively. A significant positive correlation 
was found between mean levels of MDK and AFP in HCC (P < 0.05). Combination of MDK 
and AFP improved the sensitivity of HCC diagnosis or predicting future HCC development. 
Conclusion: MDK along with AFP could be considered a promising tumor marker for HCC. 
In particular, the diagnostic value of the test is significantly increased when combined with 
AFP. 
Keywords: AFP, HCC, MDK 
Introduction 
Hepatocellular carcinoma (HCC) most 
common primary liver cancers reported 
worldwide. HCC occurs mainly in males 
and gender is an important risk factor (1). 
There are number of other cases such as 
chronic liver inflammation due to hepatitis 
B virus (HBV) and hepatitis C virus 
(HCV) infection (2, 3).  There are no 
satisfactory screening procedures for early 
detection for HCC is available, serum 
alpha fetoprotein (AFP) and ultrasound 
scan is commonly recommended (4).   
AFP is a glycoprotein molecules 
comprised of 591 amino acids with a half-
life of 5-7 days, which is synthesized by 
fetal liver cells, by yolk sac cells, and in 
trace amounts by the fetal gastrointestinal 
tract (5, 6). Reappearance of AFP in adult 
serum often signals pathologic conditions, 
particularly the presence of hepatocellular 
carcinomas (HCC) and germ cell tumors 
containing yolk sac cell elements (7, 8). In 
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60-70% of patients with HCC high serum 
AFP has been reported, but there are other 
causes in which increased levels are seen, 
such as cirrhosis, lung cancer, biliary 
cancer, gastric cancer, pancreatic cancer, 
teratocarcinoma of the testis, spherocytosis 
and tyrosinemia (9). Although AFP has 
certain limitation which compels to search 
for other prognostic marker, so we 
investigated the clinical value of serum 
MDK in diagnosing primary 
hepatocellular carcinoma along with AFP. 
Midkine (MDK), also known as neurite 
growth-promoting factor 2 (NEGF2), is a 
basic heparin-binding growth factor of 13-
kDa protein rich in a basic amino acid and 
cysteine. In humans, it is encoded by the 
MDK gene on chromosome 11 (10). In 
majority of cases MK level  in serum 
samples was that 0.6–0.8 ng/mL, whereas 
the MK levels in the sera of normal human 
subjects were low or undetectable (11). In 
addition, the overexpression level of MK 
in HCC with intra-hepatic metastasis was 
significantly higher than that in HCC 
without intra-hepatic metastasis (12). It is 
noteworthy that a significant increase in 
serum MK is associated with HCC 
patients, including those with normal 
serum AFP concentrations (13). 
Furthermore, serum MDK levels are 
reportedly higher in patients with HCC 
than in those without (14). 
New biomarkers for earlier diagnosis of 
HCC with high sensitivity and 
identification of high risk groups are 
required. 
Materials and methods 
Patients: The study involved 60 subjects 
who were divided into two groups. The 
control group consisted of 30 healthy 
subjects (26 women and 14 men) with an 
average age of 56.34 years, who were from 
30 to 70 years old; they also did not have 
family history of HCC and they were not 
medically treated. Rest 30 subjects were 
diagnosed with HCC. Detailed clinical 
history and examination were carried out 
and recorded in preformed Performa. The 
study conducted in the Department of 
Biochemistry in collaboration with the 
Department of Gastroenterology, during 
the period from Jan 2010 to March 2012. 
Blood samples were collected from eighty 
patients who were attending to Indira 
Gandhi Institute of Medical Sciences Patna 
teaching hospital. Blood samples were 
taken from an antecubital vein of the 
forearm of each study subject, after 
overnight fasting. Blood was centrifuged 
and the separated serum then frozen       at 
-20 ºC for subsequent analysis. 
Serum AFP level was performed by 
chemiluminescent immunoassay method 
on a Beckman coulter. Serum MDK was 
titered using a commercial enzyme-linked 
immunosorbent assay kit (Human MDK 
Immunoassay, R&D Systems, 
Minneapolis, MN) following the 
manufacturer’s instructions and the results 
were expressed as pg/ml. 
Statistical Analysis 
The data of the study subjected to 
statistical analysis is expressed as        
mean ± SD. Statistical comparisons were 
performed by Student t-test. 
Results  
Form 60 patients, 26 (65%) of them were 
women while only 14 (35%) of who were 
men. The mean age of the patients was 
56.34 ± 11.01 years (56.26 ± 6.62 years for 
women and 53.56 ± 7.13 years for 
men).The mean serum AFP level in case 
HCC was   (594.62 ± 315.99 pg/ml) and in 
control was (3.13 ± 1.27 pg/ml) (Table 1).   
It is interesting to note that a large number 
of patients, both males and females with 
elevated levels of AFP are basically 
diagnosed with HCV or HBV infections. 
Chronic hepatitis C patients had 
signiﬁcantly higher serum MDK levels 
than healthy controls (18 ± 9.8 pg/ml) vs. 
(2.29 ± 4.10 pg/ml), p < 0.01) and the 
difference was similar in male and female.
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Table 1. Serum levels of α-fetoprotein and MDK in 
patients under study. 
Groups AFP MDK 
Control 
(N=30) 
2.89±1.01 0.69±.10 
HCC       
(N=30) 
298.89±492.01*** 2.29±4.10** 
***P<0.005, **p<0.01 
Discussion 
AFP was discovered by Bergstrand and 
Czar (15) in 1956 using paper for its 
electrophoretic separation from human 
fetoprotein in serum, and it was first 
described by Abelev et al. (16) in 1960.  
The first quantitative serum assays for 
AFP were established by Ruoshlati and 
Seppala (17). Up to 11 AFP isoforms exist 
based on variations in the glycan terminal 
chain (18, 19).  Taketa et al. found AFP-
L3 to be positive in about 35% of patients 
with HCC smaller than 2 cm, which may 
be present in serum up to 9 months before 
detection by imaging techniques (20). 
More recently, isoelectric focusing has 
been investigated, which fractionates AFP 
into four variant bands, I-IV. AFP bands 
III and IV can be specific for HCC and 
help differentiate from AFP of cirrhosis or 
pregnancy (21). Chronic hepatitis or 
cirrhosis raise AFP in 20% and 50% of 
patients, respectively, and tend to fluctuate
 in parallel with underlying inflammatory 
activity (22). The sensitivity of AFP is low 
renders it unsatisfactory for this purpose 
and compels to search for novel 
biomarkers for the detection of early HCC 
(23).  
 Midkine (MK), a plasma secreted protein, 
was initially identified in embryonal 
carcinoma cells at early stages of retinoic 
acid-induced differentiation. Multiple 
studies have reported that MK plays 
important roles in tumor progression, and is 
highly expressed in various malignant 
tumors. Because increased serum MK 
concentrations also have been reported in 
patients with various tumors, serum MK 
may have the potential to become a very 
useful tumor marker. 
It is well documented that AFP estimation 
remains along with MDK a useful test for 
clinicians, oncologists and physicians 
involved in the management of patients of 
HCC. 
Conclusion 
In conclusion, high serum MDK level 
predates the development of HCC in 
chronic hepatitis B patients, and has 
moderate accuracy in predicting future 
cancer. This may assist clinicians in 
selecting high-risk patients for HCC 
surveillance program. Combining the two 
markers can provide a new perspective in 
the diagnosis and prognosis of HCC. 
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